Z

Zucara Therapeutics Inc.

12 employees

Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
drug therapy
insulin
hypoglycemia
Diabetes
Pharmaceutical
diabetes

Date founded

2015

Funding rounds raised

Total raised

$21M

from 7 investors over 7 rounds

Z

Zucara Therapeutics Inc. raised undisclosed on May 2, 2022

Investors: GlycoNet and Mitacs

Z

Zucara Therapeutics Inc. raised $313K on November 2, 2020

Investors: Mitacs

Z

Zucara Therapeutics Inc. raised $21M on March 31, 2020

Investors: Perceptive Advisors

Z

Zucara Therapeutics Inc. raised $69K on July 12, 2019

Investors: GlycoNet

Z

Zucara Therapeutics Inc. raised $3.9M on April 9, 2018

Investors: The Leona M and Harry B Helmsley Charitable Trust

Z

Zucara Therapeutics Inc. raised $525K on November 3, 2016

Investors: Accel-Rx - Canada's Health Science Accelerator

FAQ